Mannkind Corporation

MNKD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
MNKD Income Statement
MNKD Balance Sheet
MNKD Cash Flow
Congress Trading

Recent trades of MNKD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
MNKD Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
MNKD Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MNKD Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by MNKD's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $30,000 Oct 20, 2023 Issue: Health Issues
  • $30,000 Jan 19, 2023 Issue: Health Issues
  • $30,000 Oct 18, 2022 Issue: Health Issues
  • $20,000 Apr 20, 2022 Issue: Health Issues
  • $30,000 Jan 20, 2022 Issue: Health Issues
  • $30,000 Oct 20, 2021 Issue: Medicare/Medicaid
  • $30,000 Jul 21, 2021 Issue: Medicare/Medicaid
  • $30,000 Jun 22, 2021 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Blister package for pharmaceutical cartridges Oct. 29, 2024
  • Patent Title: Dry powder drug delivery system and methods Oct. 29, 2024
  • Patent Title: Formation of n-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-n-protected amino ester Jul. 30, 2024
  • Patent Title: Adapter for a fluid transfer device Jul. 23, 2024
  • Patent Title: Dry powder inhaler and system for drug delivery Jun. 04, 2024
  • Patent Title: Method of treating diabetes type 2 by administering ultrarapid acting insulin Jun. 04, 2024
  • Patent Title: Method of treating hypoglycemia events in diabetes treatment May. 14, 2024
  • Patent Title: Cartridge insertion mechanism for a fluid delivery device Apr. 09, 2024
  • Patent Title: Use of ultrarapid acting insulin Mar. 19, 2024
  • Patent Title: Diketopiperazine salts for drug delivery and related methods Jan. 16, 2024
  • Patent Title: Apparatus and method for cryogranulating a pharmaceutical composition Dec. 12, 2023
  • Patent Title: Interactive apparatus and method for real-time profiling of inhalation efforts Oct. 24, 2023
  • Patent Title: Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them Oct. 24, 2023
  • Patent Title: Time delay mechanism for a hydraulic drug delivery device Aug. 22, 2023
  • Patent Title: Communication accessory for a drug delivery device Aug. 08, 2023
  • Patent Title: Moving basal engine for a fluid delivery device Jun. 06, 2023
  • Patent Title: Fluid delivery device having an insertable prefilled cartridge May. 30, 2023
  • Patent Title: Hydraulically actuated pump for fluid administration May. 09, 2023
  • Patent Title: Dry powder drug delivery system and methods Apr. 11, 2023
  • Patent Title: Diketopiperazine microparticles with defined specific surface areas Mar. 21, 2023
  • Patent Title: Use of ultrarapid acting insulin Jan. 24, 2023
  • Patent Title: Methods for the synthesis of activated ethylfumarates and their use as intermediates Oct. 25, 2022
  • Patent Title: Apparatus, system and method for detecting and monitoring inhalations Oct. 25, 2022
  • Patent Title: Insufflation apparatus and methods Sep. 20, 2022
  • Patent Title: Formation of n-protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine Sep. 13, 2022
  • Patent Title: High capacity diketopiperazine microparticles and methods Sep. 06, 2022
  • Patent Title: Formation of n-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-n-protected amino ester May. 31, 2022
  • Patent Title: Inhalable dry powder pharmaceutical composition Apr. 19, 2022
  • Patent Title: Catalysis of diketopiperazine synthesis Apr. 05, 2022
  • Patent Title: Dry powder inhaler and system for drug delivery Feb. 08, 2022
  • Patent Title: Microcrystalline diketopiperazine compositions and methods Dec. 07, 2021
  • Patent Title: Dry powder inhaler and system for drug delivery Nov. 30, 2021
  • Patent Title: Composition and method for reducing hypoglycemia events in diabetes treatment Sep. 07, 2021
  • Patent Title: Reactor for producing pharmaceutical particles in a precipitation process Aug. 31, 2021
  • Patent Title: Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces Aug. 31, 2021
  • Patent Title: Apparatus and method for cryogranulating a pharmaceutical composition Aug. 03, 2021
  • Patent Title: Use of ultrarapid acting insulin May. 25, 2021
  • Patent Title: Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents May. 25, 2021
  • Patent Title: Heat-stable dry powder pharmaceutical compositions and methods May. 25, 2021
  • Patent Title: Diketopiperazine salts for drug delivery and related methods Feb. 09, 2021
  • Patent Title: Formation of n-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic α-n-protected amino ester Dec. 22, 2020
  • Patent Title: Methods for the synthesis of activated ethylfumarates and their use as intermediates Dec. 08, 2020
  • Patent Title: Method of treating diabetes type 2 by administering ultrarapid acting insulin Dec. 08, 2020
  • Patent Title: Use of ultrarapid acting insulin Sep. 15, 2020
  • Patent Title: Diketopiperazine microparticles with defined specific surface areas Sep. 15, 2020
  • Patent Title: Dry powder inhaler and system for drug delivery Aug. 25, 2020
  • Patent Title: Microcrystalline diketopiperazine compositions and methods Aug. 18, 2020
  • Patent Title: Dry powder drug delivery system and methods Aug. 18, 2020
  • Patent Title: Interactive apparatus and method for real-time profiling of inhalation efforts Jun. 09, 2020
  • Patent Title: Formation of n-protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine May. 05, 2020
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of MNKD in WallStreetBets Daily Discussion

MNKD News

Recent insights relating to MNKD

CNBC Recommendations

Recent picks made for MNKD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MNKD

MNKD Top Shareholders
Shareholder
Shares Held
MNKD Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MNKD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MNKD Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top